129 related articles for article (PubMed ID: 26478474)
1. A call for the better utilization of physical activity and exercise training in the defense against cardiovascular disease.
Murlasits Z
Phys Sportsmed; 2015 Nov; 43(4):329-32. PubMed ID: 26478474
[TBL] [Abstract][Full Text] [Related]
2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
4. Statin Therapy as Primary Prevention in Exercising Adults: Best Evidence for Avoiding Myalgia.
Bosomworth NJ
J Am Board Fam Med; 2016 Nov; 29(6):727-740. PubMed ID: 28076256
[TBL] [Abstract][Full Text] [Related]
5. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
6. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
7. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Postgrad Med J; 2008 Nov; 84(997):590-8. PubMed ID: 19103817
[TBL] [Abstract][Full Text] [Related]
8. The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations.
Schweitzer AM; Gingrich MA; Hawke TJ; Rebalka IA
Eur J Appl Physiol; 2020 Jun; 120(6):1205-1225. PubMed ID: 32248287
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis.
Gui YJ; Liao CX; Liu Q; Guo Y; Yang T; Chen JY; Wang YT; Hu JH; Xu DY
Eur J Prev Cardiol; 2017 Jun; 24(9):907-916. PubMed ID: 28436720
[TBL] [Abstract][Full Text] [Related]
10. Statins, cardiovascular disease, and drug safety.
Gotto AM
Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326
[TBL] [Abstract][Full Text] [Related]
11. The effects of statin medications on aerobic exercise capacity and training adaptations.
Murlasits Z; Radák Z
Sports Med; 2014 Nov; 44(11):1519-30. PubMed ID: 25012079
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review.
Pfefferkorn JA
Expert Opin Ther Pat; 2011 Feb; 21(2):187-203. PubMed ID: 21214503
[TBL] [Abstract][Full Text] [Related]
13. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
14. Nonstatin therapies for management of dyslipidemia: a review.
Sando KR; Knight M
Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
Fabbri G; Maggioni AP
Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
[TBL] [Abstract][Full Text] [Related]
16. Intensive statin therapy for Indians: Part-I. Benefits.
Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
Jones PH
Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
[TBL] [Abstract][Full Text] [Related]
19. A review of perioperative statin therapy for noncardiac surgery.
Skrlin S; Hou V
Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based use of statins for primary prevention of cardiovascular disease.
Minder CM; Blaha MJ; Horne A; Michos ED; Kaul S; Blumenthal RS
Am J Med; 2012 May; 125(5):440-6. PubMed ID: 22387091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
